Horizon Financial Services, LLC Geo Vax Labs, Inc. Transaction History

Horizon Financial Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change
Q4 2021 Jan 31, 2022	SELL	$52.65 - $71.7 $0 - $0	0 Closed
Q3 2021 Oct 22, 2021	BUY	$56.4 - $91.35 $0 - $0	0 New
Q2 2021 Jul 22, 2021	BUY	$64.8 - $94.5 $0 - $0	0 New
Q1 2021 Apr 21, 2021	BUY	$49.05 - $126.6 $0 - $0	0 New
Q4 2020 Jan 19, 2021	BUY	$39.45 - $85.95 $0 - $0	0 New
Q3 2020 Nov 13, 2020	BUY	$42.0 - $414.75 $0 - $0	0 New

Ticker GOVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,744,000
Market Cap $51.2M
Description
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhag...

Get notified when there are updates to the investment portfolio of Horizon Financial Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Horizon Financial Services, LLC with notifications on news.